Cite
HARVARD Citation
Muendlein, A. et al. (2022). Serum glypican-4 is a marker of future vascular risk and mortality in coronary angiography patients. Atherosclerosis. pp. 33-38. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Muendlein, A. et al. (2022). Serum glypican-4 is a marker of future vascular risk and mortality in coronary angiography patients. Atherosclerosis. pp. 33-38. [Online].